204 related articles for article (PubMed ID: 28490902)
1. Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment.
González JM; Ogale S; Morlock R; Posner J; Hauber B; Sommer N; Grothey A
Cancer Manag Res; 2017; 9():149-158. PubMed ID: 28490902
[TBL] [Abstract][Full Text] [Related]
2. Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment.
Wong XY; Lim AQJ; Shen Q; Chia JWK; Chew MH; Tan WS; Wee HL
Curr Med Res Opin; 2020 Oct; 36(10):1677-1686. PubMed ID: 32609014
[TBL] [Abstract][Full Text] [Related]
3. The effect of information on preferences for treatments of metastatic renal cell carcinoma.
Mansfield C; Srinivas S; Chen C; Hauber AB; Hariharan S; Matczak E; Sandin R
Curr Med Res Opin; 2016 Nov; 32(11):1827-1838. PubMed ID: 27404275
[TBL] [Abstract][Full Text] [Related]
4. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
[TBL] [Abstract][Full Text] [Related]
5. Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
Thomas C; Ailawadhi S; Popat R; Kleinman D; Ross MM; Gorsh B; Mulnick S; O'Neill A; Paka P; Hanna M; Krucien N; Molinari A; Gelhorn HL; Perera S
Front Med (Lausanne); 2023; 10():1271657. PubMed ID: 38076274
[TBL] [Abstract][Full Text] [Related]
6. Older adults' preferences for colorectal cancer-screening test attributes and test choice.
Kistler CE; Hess TM; Howard K; Pignone MP; Crutchfield TM; Hawley ST; Brenner AT; Ward KT; Lewis CL
Patient Prefer Adherence; 2015; 9():1005-16. PubMed ID: 26203233
[TBL] [Abstract][Full Text] [Related]
7. Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments.
Byun JH; Kwon SH; Lee JE; Cheon JE; Jang EJ; Lee EK
Patient Prefer Adherence; 2016; 10():641-50. PubMed ID: 27175064
[TBL] [Abstract][Full Text] [Related]
8. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
[TBL] [Abstract][Full Text] [Related]
9. Patient and oncologist preferences for attributes of treatments in advanced melanoma: a discrete choice experiment.
Liu FX; Witt EA; Ebbinghaus S; DiBonaventura Beyer G; Shinde R; Basurto E; Joseph RW
Patient Prefer Adherence; 2017; 11():1389-1399. PubMed ID: 28860722
[TBL] [Abstract][Full Text] [Related]
10. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
Front Public Health; 2021; 9():653450. PubMed ID: 33842426
[No Abstract] [Full Text] [Related]
11. Japanese Patients' and Physicians' Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment.
Okumura K; Inoue H; Yasaka M; Gonzalez JM; Hauber AB; Levitan B; Yuan Z; Baptiste Briere J
J Health Econ Outcomes Res; 2015; 2(2):207-220. PubMed ID: 37663581
[No Abstract] [Full Text] [Related]
12. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
[TBL] [Abstract][Full Text] [Related]
13. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.
Marshall DA; Johnson FR; Kulin NA; Ozdemir S; Walsh JM; Marshall JK; Van Bebber S; Phillips KA
Health Econ; 2009 Dec; 18(12):1420-39. PubMed ID: 19191268
[TBL] [Abstract][Full Text] [Related]
14. Benefit-risk trade-offs in treatment choice in advanced HER2 negative breast cancer: patient and oncologist perspectives.
Amin S; Tolaney SM; Cambron-Mellott MJ; Beusterien K; Maculaitis MC; Mulvihill E; Shinde R; McLaurin K
Future Oncol; 2022 May; 18(16):1927-1941. PubMed ID: 35249366
[TBL] [Abstract][Full Text] [Related]
15. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
[TBL] [Abstract][Full Text] [Related]
16. Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists.
Fernández O; Lázaro-Quintela M; Crespo G; Soto de Prado D; Pinto Á; Basterretxea L; Gómez de Liaño A; Etxaniz O; Blasco S; Gabás-Rivera C; Aceituno S; Palomar V; Polanco-Sánchez C
Front Oncol; 2021; 11():773366. PubMed ID: 35070976
[TBL] [Abstract][Full Text] [Related]
17. Patient and physician preferences for ulcerative colitis treatments in the United States.
Boeri M; Myers K; Ervin C; Marren A; DiBonaventura M; Cappelleri JC; Hauber B; Rubin DT
Clin Exp Gastroenterol; 2019; 12():263-278. PubMed ID: 31354328
[No Abstract] [Full Text] [Related]
18. Assessment of Metastatic Colorectal Cancer Patients' Preferences for Biologic Treatments in Germany Using a Discrete Choice Experiment.
Heinemann V; Singh M; Hardtstock F; Hecker D; Lebioda A; Schaller-Kranz T; Bartsch R
Clin Colorectal Cancer; 2022 Jun; 21(2):122-131. PubMed ID: 35120843
[TBL] [Abstract][Full Text] [Related]
19. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G
Front Psychol; 2023; 14():1062830. PubMed ID: 37425173
[TBL] [Abstract][Full Text] [Related]
20. Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.
Sun H; Wang H; Shi L; Wang M; Li J; Shi J; Ni M; Hu X; Chen Y
BMJ Open; 2020 Feb; 10(2):e032336. PubMed ID: 32051302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
